CID 16073753

3-quinolinecarboxylic acid, 7-[4-[(5-amino-1,3,4-thiadiazol-2-yl)sulfonyl]-1-piperazinyl]-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-

Structural Information

Molecular Formula
C19H19FN6O5S2
SMILES
C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCN(CC4)S(=O)(=O)C5=NN=C(S5)N)F)C(=O)O
InChI
InChI=1S/C19H19FN6O5S2/c20-13-7-11-14(26(10-1-2-10)9-12(16(11)27)17(28)29)8-15(13)24-3-5-25(6-4-24)33(30,31)19-23-22-18(21)32-19/h7-10H,1-6H2,(H2,21,22)(H,28,29)
InChIKey
QOLURQDHMDPAFK-UHFFFAOYSA-N
Compound name
7-[4-[(5-amino-1,3,4-thiadiazol-2-yl)sulfonyl]piperazin-1-yl]-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

494.08423 Da
Monoisotopic Mass

0.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 495.09151 211.1
[M+Na]+ 517.07345 221.6
[M-H]- 493.07695 215.5
[M+NH4]+ 512.11805 209.6
[M+K]+ 533.04739 211.7
[M+H-H2O]+ 477.08149 203.8
[M+HCOO]- 539.08243 214.3
[M+CH3COO]- 553.09808 216.5
[M+Na-2H]- 515.05890 209.3
[M]+ 494.08368 214.3
[M]- 494.08478 214.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.